Consequently, important research efforts have been made in the search for new therapeutic approaches to identify novel drugs and/or drug targets with the aim of developing alternative strategies to treat ERα-expressing BC both in the context of primary disease and in the context of metastatic disease [14]. This evidence concerns the gene ESR1 and breast cancer.